相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes
Pauliina Tuomikoski et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Review of Cardiovascular Risk Factors in Women
Odette Evangelista et al.
GENDER MEDICINE (2009)
Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk?
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Vasomotor symptoms and mortality: the Rancho Bernardo Study
Johan Svartberg et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women
Alison J. Huang et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Effect of Hot Flushes on Vascular Function A Randomized Controlled Trial
Pauliina Tuomikoski et al.
OBSTETRICS AND GYNECOLOGY (2009)
Levels of Sex Steroid and Cardiovascular Disease Measures in Premenopausal and Hormone-Treated Women at Midlife - Implications for the Timing Hypothesis
MaryFran R. Sowers et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Hot flashes and subclinical cardiovascular disease - Findings from the Study of Women's Health Across the Nation Heart Study
Rebecca C. Thurston et al.
CIRCULATION (2008)
Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review
Matjoie Hemelaar et al.
FERTILITY AND STERILITY (2008)
Menopausal complaints are associated with cardiovascular risk factors
Gerrie-Cor M. Gast et al.
HYPERTENSION (2008)
Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins
Michal Vrablik et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Jacques E. Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief
N. Panay et al.
CLIMACTERIC (2007)
Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women
Hiroyuki Sumino et al.
ATHEROSCLEROSIS (2006)
Apolipoproteins as markers and managers of coronary risk
DC Chan et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2006)
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits - an attempt to interpret the Women's Health Initiative results
Herbert Kuhl et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy
YT van der Schouw et al.
EUROPEAN HEART JOURNAL (2005)
Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the study of women across the nation (SWAN)
K Sutton-Tyrrell et al.
CIRCULATION (2005)
Hormone therapy and cardiovascular disease - still much to be learnt
TS Mikkola et al.
GYNECOLOGICAL ENDOCRINOLOGY (2005)
Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy
A Ropponen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?
KK Koh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy
S Davison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen
A Wakatsuki et al.
CIRCULATION (2002)
Estrogen replacement therapy, atherosclerosis, and vascular function
TS Mikkola et al.
CARDIOVASCULAR RESEARCH (2002)
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
G Walldius et al.
LANCET (2001)
Methodologic lessons learned from hot flash studies
JA Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women
PW Anderson et al.
MATURITAS (2001)
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000
IF Godsland
FERTILITY AND STERILITY (2001)
Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes
M Leal et al.
OBSTETRICS AND GYNECOLOGY (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Initial 17β-estradiol dose for treating vasomotor symptoms
M Notelovitz et al.
OBSTETRICS AND GYNECOLOGY (2000)
分享论文
